| Healthy control subjects | All patients |  |  | Subtype |  |  |
---|---|---|---|---|---|---|---|
 | (n = 30) | (n = 86) | p valueb | SCA (n = 34) | CCA (n = 18) | MSA (n = 34) | p valuec |
Age (years) | 64.2 ± 18.7 | 60.5 ± 10.7 | 0.001 | 57.0 ± 12.0 | 65.2 ± 10.7 | 61.3 ± 8.1 | 0.027 |
Male sex | 15 (50Â %) | 48 (55.8Â %) | 0.526 | 19 (55.9Â %) | 7 (38.9Â %) | 22 (64.7Â %) | 0.284 |
Body height (cm) | 163.5 ± 6.7 | 160.4 ± 8.2 | 0.285 | 161.1 ± 8.6 | 156.9 ± 7.9 | 161.5 ± 7.7 | 0.124 |
Body weight (kg) | 64.2 ± 18.7 | 57.3 ± 10.7 | 0.039 | 57.1 ± 10.8 | 57.9 ± 11.7 | 57.2 ± 10.3 | 0.959 |
MRI measurement | |||||||
 Cranial AP diameter (mm) | 181.6 ± 10.8 | 184.7 ± 9.3 | 0.074 | 184.1 ± 9.3 | 181.2 ± 11.7 | 187.1 ± 7.2 | 0.086 |
 Posterior cranial fossa volume (ml) | 274.0 ± 26.7 | 260.0 ± 30.0 | 0.815 | 264.7 ± 33.8 | 252.6 ± 20.2 | 259.3 ± 29.1 | 0.377 |
 Midbrain AP diameter (mm) | 15.1 ± 1.9 | 15.0 ± 2.0 | 0.711 | 14.9 ± 1.9 | 16.1 ± 1.9 | 14.5 ± 1.9 | 0.017 |
 Pons AP diameter (mm) | 22.77 ± 1.5 | 14.9 ± 2.0 | 0.711 | 15.1 ± 1.8 | 14.6 ± 1.9 | 15.1 ± 2.3 | 0.723 |
 Pons transverse diameter (mm) | 28.4 ± 4.3 | 26.4 ± 3.4 | 0.394 | 26.9 ± 2.5 | 29.4 ± 3.1 | 24.4 ± 3.0 | 0.001 |
 Cerebellar height (mm) | 55.5 ± 3.3 | 47.1 ± 6.1 | 0.000 | 48.4 ± 50 | 47.8 ± 6.4 | 45.6 ± 6.7 | 0.152 |
 Cerebellar volume (ml) | 117.6 ± 13.7 | 82.7 ± 16.6 | 0.192 | 83.4 ± 16.6 | 84.9 ± 16.2 | 78.8 ± 16.5 | 0.217 |
Correction for cranial sizea | |||||||
 Corrected Midbrain AP diameter | 0.083 ± 0.010 | 0.081 ± 0.011 | 0.417 | 0.081 ± 0.010 | 0.089 ± 0.011 | 0.078 ± 0.011 | 0.002 |
Corrected Pons AP diameter | 0.126 ± 0.008 | 0.083 ± 0.011 | 0.417 | 0.082 ± 0.010 | 0.081 ± 0.013 | 0.081 ± 0.011 | 0.928 |
 Corrected Pons transverse diameter | 0.157 ± 0.024 | 0.144 ± 0.024 | 0.406 | 0.146 ± 0.015 | 0.163 ± 0.020 | 0.131 ± 0.018 | 0.001 |
 Corrected Cerebellar height diameter | 0.306 ± 0.023 | 0.256 ± 0.038 | 0.005 | 0.264 ± 0.030 | 0.265 ± 0.042 | 0.245 ± 0.040 | 0.061 |
 Corrected Cerebellar volume diameter | 0.65 ± 0.06 | 0.49 ± 0.09 | 0.011 | 0.46 ± 0.09 | 0.47 ± 0.09 | 0.42 ± 0.09 | 0.100 |
Disease duration (years) | --- | 7.6 ± 6.4 |  | 10.5 ± 8.0 | 8.2 ± 4.6 | 4.1 ± 2.7 | 0.001 |
ICARS score | |||||||
 Total score | --- | 36.7 ± 15.3 |  | 35.7 ± 12.1 | 31.4 ± 11.3 | 40.5 ± 19.0 | 0.206 |
 Domain I | --- | 15.0 ± 7.3 |  | 13.7 ± 6.4 | 10.7 ± 5.5 | 18.5 ± 7.6 | 0.001 |
 Domain II | --- | 16.5 ± 8.5 |  | 16.4 ± 6.3 | 15.4 ± 6.6 | 17.11 ± 1.1 | 0.800 |
 Domain III | --- | 3.21 ± 0.5 |  | 2.9 ± 1.1 | 3.2 ± 1.7 | 3.4 ± 1.7 | 0.468 |
 Domain IV | --- | 1.81 ± 0.3 |  | 1.9 ± 1.4 | 1.8 ± 1.3 | 1.6 ± 1.3 | 0.263 |